Lindsey Cilia is a Cardiology physician affiliated with Inova Health System. OpenAlex indexes 28 publications with 326 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202552 payments$19,640openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year202530 payments$10,987openpaymentsdata.cms.gov ↗
- ABIOMEDProgram year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
89.4%Statin23.7%Atorvastatin Calcium56%Rosuvastatin Calcium36%Pravastatin Sodium9%Part D<11 patientsBeta blocker16%Metoprolol Succinate70%Carvedilol18%Metoprolol Tartrate12%Part D≥55 patients+ 11 more classes in this area
Blood & clotting
9.6%Factor Xa inhibitor5.7%Eliquis66%Xarelto34%Part D<11 patientsP2Y12 inhibitor3.9%Clopidogrel100%Part D≥21 patientsMetabolism & gastrointestinal
1%Proton pump inhibitor1%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Optimal Large-Bore Vascular Access and Closure for Percutaneous Mechanical Circulatory Support in Cardiogenic Shock
Interventional Cardiology Clinics
2026 - Protamine Use During Chronic Total Occlusion Percutaneous Coronary Intervention: A Multicenter Registry
Catheterization and Cardiovascular Interventions
2026 - Beyond the guidelines: expert perspectives on the management of AMI-related cardiogenic shock from the Cardiovascular Research Technologies (CRT) 2025 meeting
Cardiovascular revascularization medicine
2025 - Editorial: Revascularization of chronic total occlusions following acute coronary syndromes: Is time of the essence or better late than never?
Cardiovascular revascularization medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
William Ershler, MD
Inova Health System
Wayne Batchelor, MD
Inova Health System
Mitchell Psotka, MD, PhD
Inova Health System
Brett Atwater, MD
Inova Health System
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”